Inositol 1,4,5-trisphosphate (IP 3 ) receptors are endoplasmic reticulum membrane calcium channels that, upon activation, are degraded via the ubiquitin-proteasome pathway. While searching for novel mediators of IP 3 receptor processing, we discovered that RNF170, an uncharacterized RING domaincontaining protein, associates rapidly with activated IP 3 receptors. RNF170 is predicted to have three membrane-spanning helices, is localized to the ER membrane, and possesses ubiquitin ligase activity. Depletion of endogenous RNF170 by RNA interference inhibited stimulus-induced IP 3 receptor ubiquitination, and degradation and overexpression of a catalytically inactive RNF170 mutant suppressed stimulus-induced IP 3 receptor processing. A substantial proportion of RNF170 is constitutively associated with the erlin1/2 (SPFH1/2) complex, which has been shown previously to bind to IP 3 receptors immediately after their activation. Depletion of RNF170 did not affect the binding of the erlin1/2 complex to stimulated IP 3 receptors, whereas erlin1/2 complex depletion inhibited RNF170 binding. These results suggest a model in which the erlin1/2 complex recruits RNF170 to activated IP 3 receptors where it mediates IP 3 receptor ubiquitination. Thus, RNF170 plays an essential role in IP 3 receptor processing via the ubiquitin-proteasome pathway.Inositol 1,4,5-trisphosphate (IP 3 ) 3 receptors form tetrameric, IP 3 -and Ca 2Ï© -gated Ca 2Ï© channels in endoplasmic reticulum (ER) membranes of mammalian cells and play a key role in cell signaling (1). Stimulation of certain cell surface receptors triggers IP 3 formation at the plasma membrane, which then diffuses through the cytosol and binds to IP 3 receptors (1). This, in concert with Ca 2Ï© binding, induces yet to be defined conformational changes in the tetrameric channel that permit Ca 2Ï© to flow from stores within the ER lumen into the cytosol (1). There are three IP 3 receptor types in mammals, IP 3 R1, IP 3 R2, and IP 3 R3, and although they differ considerably in their tissue distribution, they have broadly similar properties and are often coexpressed (1).In recent years it has become clear that G-protein-coupled receptor-induced activation of endogenous IP 3 receptors can lead to their rapid degradation via the ubiquitin-proteasome pathway (UPP) (2). This IP 3 receptor "down-regulation" has been demonstrated in many mammalian cell types, including gonadotropin-releasing hormone (GnRH)-stimulated âŁT3-1 mouse pituitary gonadotropes (3), endothelin 1 (ET1)-stimulated Rat1 fibroblasts (4), and muscarinic agonist-stimulated SH-SY5Y human neuroblastoma cells (5) and mHeLa cells (6).The generally accepted summary of the UPP is that substrates are first polyubiquitinated and then processed by the proteasome, a multi-subunit protease that can recognize and degrade polyubiquitinated proteins (7,8). Ubiquitination, the key step in targeting a protein for proteasomal degradation, is achieved through the hierarchical action of three enzymes, termed ubiquitin-activating enzyme (E1), ubiqu...